Abstract: The present invention relates to a composition comprising of a CD47-SIRPa blocking agent and one or more anti-cancer agent(s): wherein the CD47-SIRPa blocking agent is represented by compound of formula (I). The present invention also relates to a method of treating cancer in a subject by administering therapeutically effective amount of CD47-SIRPa blocking agent represented by formula (I) in combination with one or more anti-cancer agent(s).
| # | Name | Date |
|---|---|---|
| 1 | 202147024578-FORM 1 [02-06-2021(online)].pdf | 2021-06-02 |
| 2 | 202147024578-DRAWINGS [02-06-2021(online)].pdf | 2021-06-02 |
| 3 | 202147024578-COMPLETE SPECIFICATION [02-06-2021(online)].pdf | 2021-06-02 |
| 4 | 202147024578-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [02-06-2021(online)].pdf | 2021-06-02 |
| 5 | 202147024578-ENDORSEMENT BY INVENTORS [17-06-2021(online)].pdf | 2021-06-17 |
| 6 | 202147024578-Proof of Right [05-07-2021(online)].pdf | 2021-07-05 |
| 7 | 202147024578-Proof of Right [07-07-2021(online)].pdf | 2021-07-07 |
| 8 | 202147024578-Correspondence, Form-26_09-07-2021.pdf | 2021-07-09 |
| 9 | 202147024578.pdf | 2021-10-18 |
| 10 | 202147024578-FORM 3 [04-07-2022(online)].pdf | 2022-07-04 |
| 11 | 202147024578-RELEVANT DOCUMENTS [10-01-2023(online)].pdf | 2023-01-10 |
| 12 | 202147024578-FORM 3 [10-01-2023(online)].pdf | 2023-01-10 |
| 13 | 202147024578-FORM 13 [10-01-2023(online)].pdf | 2023-01-10 |
| 14 | 202147024578-PETITION UNDER RULE 138 [08-02-2023(online)].pdf | 2023-02-08 |
| 15 | 202147024578-PETITION UNDER RULE 137 [08-02-2023(online)].pdf | 2023-02-08 |
| 16 | 202147024578-Retyped Pages under Rule 14(1) [09-02-2023(online)].pdf | 2023-02-09 |
| 17 | 202147024578-2. Marked Copy under Rule 14(2) [09-02-2023(online)].pdf | 2023-02-09 |
| 18 | 202147024578-FORM 3 [14-02-2023(online)].pdf | 2023-02-14 |
| 19 | 202147024578-FORM 3 [09-08-2023(online)].pdf | 2023-08-09 |